A novel guaiane sesquiterpene derivative, guai-2-en-10α-ol, from Ulva fasciata Delile inhibits EGFR/PI3K/Akt signaling and induces cytotoxicity in triple-negative breast cancer cells
- 1 August 2017
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 438 (1-2) , 123-139
Abstract
A novel guaiane sesquiterpene derivative, guai-2-en-10α-ol, from Ulva fasciata Delile exhibits antimicrobial property. U. fasciata extract was reported to exhibit cytotoxicity against cancer. In the present study, we have studied the anticancer potential of the compound, guai-2-en-10α-ol, from U. fasciata. The compound showed selective cytotoxicity toward triple-negative breast cancer (TNBC) cell line (MDA MB-231) in a dose-dependent manner. In treated cells, the apoptotic hallmarks such as formation of apoptotic bodies, cell shrinkage, and nuclear condensation were observed. Many small molecules affect the function of cellular signaling pathways. As EGFR/PI3K/Akt pathway proteins are frequently altered in TNBC, we have studied the gene expression of key proteins of this pathway. The semiquantitative PCR results demonstrated the down-regulated expression of PDPK1 (positive regulator) and Akt (key activator) as well as up-regulated expression of PTEN (negative regulator), which suggested the interaction of guai-2-en-10α-ol with upstream protein. Further investigation showed the down-regulation of both PI3K and EGFR. As EGFR is the most upstream protein of the pathway, its protein level expression was investigated. Western blotting analysis confirmed the down-regulation of p-EGFR expression and activation of apoptosis upon compound treatment. Cell cycle analysis also evidenced the G1 phase arrest, which can be due to the inhibition of cell survival pathway. Computational studies showed the interaction of guai-2-en-10α-ol with Asp855 residue of EGFR kinase domain in active conformation. All these results demonstrate the anticancer potential of guai-2-en-10α-ol through EGFR/PI3K/Akt pathway.Keywords
Funding Information
- DBT-BUILDER (BT/PR14554/INF/22/125/2010)
- UGC-SAP
This publication has 33 references indexed in Scilit:
- Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κBJournal of Experimental & Clinical Cancer Research, 2012
- SwissParam: A fast force field generation tool for small organic moleculesJournal of Computational Chemistry, 2011
- Apoptosis Inducing Effect of Plumbagin on Colonic Cancer Cells Depends on Expression of COX-2PLOS ONE, 2011
- Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast CancerThe Oncologist, 2011
- Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiencyThe Journal of Chemical Physics, 2010
- Anticancer Drugs from Marine Flora: An OverviewJournal of Oncology, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancerAnnals of Oncology, 2009
- PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cellsVirology, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005